This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

PASI (psoriasis area and severity index)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Psoriasis areas and severity index (PASI) score denotes an objective method of scoring severity of psoriasis, reflecting not only the body surface area but also erythema, induration and scaling

  • PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 (no disease) to 72 (maximal disease)
  • body is divided into four sections based on the estimated area of skin affected:

    • head - 10%
    • arms - 20%
    • trunk - 30%
    • legs - 40%

      • Each of these areas is scored by itself, and then the four scores are combined into the final PASI
        • For each section, the percent of area of skin involved, is estimated and then transformed into a grade from 0 to 6:

          • grade 0: 0% of involved area

          • grade 1: < 10% of involved area

          • grade 2: 10-29% of involved area

          • grade 3: 30-49% of involved area

          • grade 4: 50-69% of involved area

          • grade 5: 70-89% of involved area

          • grade 6: 90-100% of involved area

Within each area, the severity is estimated by three clinical signs:

  • erythema (redness)
  • induration (thickness)
  • desquamation (scaling)
  • severity parameters are measured on a scale of 0 to 4

The sum of all three severity parameters is then calculated for each section of skin, multiplied by the area score for that area and multiplied by weight of respective section (0.1 for head, 0.2 for arms, 0.3 for body and 0.4 for legs).

Be aware that (1):

  • PASI and body surface area are not validated for use in children and young people
  • erythema may be underestimated in people with darker skin types, such as skin types V and VI on the Fitzpatrick scale

Reference:

1. Psoriasis: The assessment and management of psoriasis. NICE Clinical Guideline (October 2012 - last updated September 2017)


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.